NorjuziphineCAS# 74119-87-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 74119-87-2 | SDF | Download SDF |
PubChem ID | 15690955 | Appearance | Cryst. |
Formula | C17H19NO3 | M.Wt | 285.3 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol | ||
SMILES | COC1=C(C2=C(CCNC2CC3=CC=C(C=C3)O)C=C1)O | ||
Standard InChIKey | BXWMZVREXWPYKF-CQSZACIVSA-N | ||
Standard InChI | InChI=1S/C17H19NO3/c1-21-15-7-4-12-8-9-18-14(16(12)17(15)20)10-11-2-5-13(19)6-3-11/h2-7,14,18-20H,8-10H2,1H3/t14-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Norjuziphine has antiplatelet aggregation activity. |
Norjuziphine Dilution Calculator
Norjuziphine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.5051 mL | 17.5254 mL | 35.0508 mL | 70.1016 mL | 87.6271 mL |
5 mM | 0.701 mL | 3.5051 mL | 7.0102 mL | 14.0203 mL | 17.5254 mL |
10 mM | 0.3505 mL | 1.7525 mL | 3.5051 mL | 7.0102 mL | 8.7627 mL |
50 mM | 0.0701 mL | 0.3505 mL | 0.701 mL | 1.402 mL | 1.7525 mL |
100 mM | 0.0351 mL | 0.1753 mL | 0.3505 mL | 0.701 mL | 0.8763 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- SKF 83822 hydrobromide
Catalog No.:BCC7252
CAS No.:74115-10-9
- Ketorolac tromethamine salt
Catalog No.:BCC4431
CAS No.:74103-07-4
- Ketorolac
Catalog No.:BCC5190
CAS No.:74103-06-3
- ACV 1
Catalog No.:BCC5989
CAS No.:740980-24-9
- Cudratricusxanthone A
Catalog No.:BCN7649
CAS No.:740810-42-8
- Macamide B
Catalog No.:BCN1366
CAS No.:74058-71-2
- Ketanserin
Catalog No.:BCC5050
CAS No.:74050-98-9
- Lancifolin C
Catalog No.:BCN2019
CAS No.:74048-71-8
- Enoxacin (Penetrex)
Catalog No.:BCC3775
CAS No.:74011-58-8
- p-Hydroxy-cinnamic acid
Catalog No.:BCN5027
CAS No.:7400-08-0
- Mosloflavone
Catalog No.:BCN6796
CAS No.:740-33-0
- L-Arginine
Catalog No.:BCN2691
CAS No.:74-79-3
- DSC
Catalog No.:BCC2800
CAS No.:74124-79-1
- Bisdethiobis(methylthio)gliotoxin
Catalog No.:BCN7351
CAS No.:74149-38-5
- Pimobendan
Catalog No.:BCC2294
CAS No.:74150-27-9
- 2,3-Dehydrokievitone
Catalog No.:BCN4294
CAS No.:74161-25-4
- R547
Catalog No.:BCC3927
CAS No.:741713-40-6
- Haginin A
Catalog No.:BCN6861
CAS No.:74174-29-1
- Cyclokievitone
Catalog No.:BCC8159
CAS No.:74175-82-9
- Doxazosin
Catalog No.:BCC4218
CAS No.:74191-85-8
- Uplandicine
Catalog No.:BCN2055
CAS No.:74202-10-1
- 3-Bromo-7-nitroindazole
Catalog No.:BCC6770
CAS No.:74209-34-0
- Vintafolide
Catalog No.:BCC5265
CAS No.:742092-03-1
- Carbenoxolone disodium
Catalog No.:BCC3745
CAS No.:7421-40-1
A new tetrahydroprotoberberine N-oxide alkaloid and anti-platelet aggregation constituents of Corydalis tashiroi.[Pubmed:11488455]
Planta Med. 2001 Jul;67(5):423-7.
A new tetrahydroprotoberberine N-oxide alkaloid, (-)-cis-isocorypalmine N-oxide (1), together with two known compounds, 6-methoxydihydrosanguinarine (2) and Norjuziphine (3), were isolated in continuing studies of the entire Formosan Corydalis tashiroi plant. The structures of these three compounds were determined through spectral analyses. In addition, compounds 1, 2, 3 and the seven alkaloids previously reported: (-)-cis-corydalmine N-oxide, (-)-trans-corydalmine N-oxide, (-)-trans-isocorypalmine N-oxide, scoulerine, protopine, oxysanguinarine and corydalmine, were found to possess antiplatelet aggregation activity.
Additional alkaloids of Pachygone ovata.[Pubmed:6481360]
J Nat Prod. 1984 May-Jun;47(3):459-64.
Pachygone ovata (Menispermaceae), indigenous to the sandy seashores of southern India, is a woody climber whose fruits have been used as a rodenticide and fish poison. Chromatography of the extract of the roots resulted in the reisolation of the alkaloids liriodenine, coclaurine, trilobine (1), and magnoflorine and the isolation of stepholidine, coreximine, isoboldine, Norjuziphine, and nortrilobine (2). Nortrilobine (2) is a new dibenzo-p-dioxin bisbenzylisoquinoline alkaloid whose structure was established by a consideration of spectral data and conversion to isotrilobine (3).